13F HOLDINGS REPORT
Rhenman & Partners Asset Management AB
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0001213900-24-097092
Total Value
$1.23B
Positions
95
Other Managers
0
Confidential Omitted
No
Holdings (95)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BOSTON SCIENTIFIC CORP | BSX | 590,000 | $49.4M | 4.01% |
| 2 | UNITED HEALTH GROUP INC | UNH | 72,700 | $42.5M | 3.45% |
| 3 | LILLY ELI & CO | LLY | 47,500 | $42.1M | 3.42% |
| 4 | REGENERON PHARMACEUTICALS | REGN | 39,000 | $41.0M | 3.33% |
| 5 | TENET HEALTHCARE CORP | THC | 221,400 | $36.8M | 2.99% |
| 6 | PROCEPT BIOROBOTICS CORP | PRCT | 445,000 | $35.7M | 2.89% |
| 7 | ABBVIE INC | ABBV | 177,000 | $35.0M | 2.84% |
| 8 | MEDTRONIC PLC | MDT | 368,000 | $33.1M | 2.69% |
| 9 | EXACT SCIENCES CORP | 30063P105 | 465,000 | $31.7M | 2.57% |
| 10 | HCA HEALTHCARE INC | HCA | 76,229 | $31.0M | 2.51% |
| 11 | INTUITIVE SURGICAL INC | ISRG | 63,000 | $31.0M | 2.51% |
| 12 | GILEAD SCIENCES INC | GILD | 366,500 | $30.7M | 2.49% |
| 13 | NATERA INC | NTRA | 231,000 | $29.3M | 2.38% |
| 14 | OSCAR HEALTH INC | OSCR | 1,371,147 | $29.1M | 2.36% |
| 15 | MERCK & CO. INC | MRK | 241,000 | $27.4M | 2.22% |
| 16 | BECTON DICKINSON & CO | BDX | 112,500 | $27.1M | 2.20% |
| 17 | ELEVANCE HEALTH INC | ELV | 50,500 | $26.3M | 2.13% |
| 18 | INSPIRE MED SYS INC | 457730109 | 122,000 | $25.7M | 2.09% |
| 19 | BIOMARIN PHARMACEUTICAL INC | BMRN | 364,500 | $25.6M | 2.08% |
| 20 | COOPER COS INC | 216648501 | 228,000 | $25.2M | 2.04% |
| 21 | ALIGNMENT HEALTHCARE INC | ALHC | 1,977,363 | $23.4M | 1.90% |
| 22 | DANAHER CORPORATION | 235851102 | 83,302 | $23.2M | 1.88% |
| 23 | VERTEX PHARMACEUTICALS INC | VRTX | 47,750 | $22.2M | 1.80% |
| 24 | ROYALTY PHARMA PLC | RPRX | 613,500 | $17.4M | 1.41% |
| 25 | THERMO FISHER SCIENTIFIC INC | TMO | 25,100 | $15.5M | 1.26% |
| 26 | ABBOTT LABS | ABLZF | 135,000 | $15.4M | 1.25% |
| 27 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 205,500 | $15.0M | 1.22% |
| 28 | MCKESSON CORP | MCK | 30,117 | $14.9M | 1.21% |
| 29 | GLAUKOS CORP | GKOS | 111,000 | $14.5M | 1.17% |
| 30 | THE CIGNA GROUP | 125523100 | 41,685 | $14.4M | 1.17% |
| 31 | ALIGN TECHNOLOGY INC | ALGN | 55,000 | $14.0M | 1.14% |
| 32 | ALNYLAM PHARMACEUTICALS INC | ALNY | 50,350 | $13.8M | 1.12% |
| 33 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 1,190,000 | $13.3M | 1.08% |
| 34 | BIOGEN INC | BIIB | 67,100 | $13.0M | 1.06% |
| 35 | NOVO-NORDISK A S | NONOF | 100,000 | $11.9M | 0.97% |
| 36 | CVS HEALTH CORP | CVS | 184,000 | $11.6M | 0.94% |
| 37 | IQVIA HLDGS INC | IQV | 48,000 | $11.4M | 0.92% |
| 38 | AXSOME THERAPEUTICS INC | AXSM | 122,600 | $11.0M | 0.89% |
| 39 | APELLIS PHARMACEUTICALS INC | APLS | 367,500 | $10.6M | 0.86% |
| 40 | JAZZ PHARMACEUTICALS PLC | JAZZ | 93,000 | $10.4M | 0.84% |
| 41 | MOLINA HEALTHCARE INC | MOH | 29,600 | $10.2M | 0.83% |
| 42 | CENCORA INC | COR | 45,150 | $10.2M | 0.82% |
| 43 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 1,052,500 | $9.9M | 0.80% |
| 44 | HUMANA INC | HUM | 31,000 | $9.8M | 0.80% |
| 45 | CYTOKINETICS INC | CYTK | 180,500 | $9.5M | 0.77% |
| 46 | INSMED INC | INSM | 129,513 | $9.5M | 0.77% |
| 47 | INSULET CORP | PODD | 40,000 | $9.3M | 0.76% |
| 48 | NUVALENT INC | NUVL | 90,000 | $9.2M | 0.75% |
| 49 | CENTENE CORP DEL | CNC | 116,982 | $8.8M | 0.71% |
| 50 | STRYKER CORPORATION | SYK | 23,000 | $8.3M | 0.67% |
| 51 | NEUROCRINE BIOSCIENCES INC | NBIX | 71,750 | $8.3M | 0.67% |
| 52 | IONIS PHARMACEUTICALS INC | IONS | 195,000 | $7.8M | 0.63% |
| 53 | EVOLENT HEALTH INC | EVH | 265,000 | $7.5M | 0.61% |
| 54 | CHARLES RIV LABS INTL INC | 159864107 | 37,500 | $7.4M | 0.60% |
| 55 | TRANSMEDICS GROUP INC | TMDX | 45,270 | $7.1M | 0.58% |
| 56 | IMMUNOVANT INC | IMVT | 243,000 | $6.9M | 0.56% |
| 57 | BRIDGEBIO PHARMA INC | BBIO | 268,000 | $6.8M | 0.55% |
| 58 | NURIX THERAPEUTICS INC | NRIX | 300,000 | $6.7M | 0.55% |
| 59 | ACADIA HEALTHCARE COMPANY INC | ACHC | 105,750 | $6.7M | 0.54% |
| 60 | VIKING THERAPEUTICS INC | VKTX | 102,500 | $6.5M | 0.53% |
| 61 | BIONTECH SE | BNTX | 51,000 | $6.1M | 0.49% |
| 62 | ENCOMPASS HEALTH CORP | EHC | 61,000 | $5.9M | 0.48% |
| 63 | DEXCOM INC | DXCM | 87,000 | $5.8M | 0.47% |
| 64 | SYNDAX PHARMACEUTICALS INC | SNDX | 259,500 | $5.0M | 0.41% |
| 65 | ESSA PHARMA INC | 29668H708 | 804,649 | $4.9M | 0.40% |
| 66 | JANUX THERAPEUTICS INC | JANX | 106,847 | $4.9M | 0.39% |
| 67 | GERON CORP | GERN | 1,000,000 | $4.5M | 0.37% |
| 68 | DIANTHUS THERAPEUTICS INC | DNTH | 150,000 | $4.1M | 0.33% |
| 69 | XENCOR INC | XNCR | 203,750 | $4.1M | 0.33% |
| 70 | MIRUM PHARMACEUTICALS INC | MIRM | 105,000 | $4.1M | 0.33% |
| 71 | IDEAYA BIOSCIENCES INC | IDYA | 127,500 | $4.0M | 0.33% |
| 72 | TG THERAPEUTICS INC | TGTX | 171,500 | $4.0M | 0.33% |
| 73 | MERUS N V | N5749R100 | 79,500 | $4.0M | 0.32% |
| 74 | ALKERMES PLC | ALKS | 133,000 | $3.7M | 0.30% |
| 75 | ANNEXON INC | ANNX | 560,000 | $3.3M | 0.27% |
| 76 | ESPERION THERAPEUTICS INC NE | ESPR | 1,975,000 | $3.3M | 0.26% |
| 77 | RELAY THERAPEUTICS INC | RLAY | 460,000 | $3.3M | 0.26% |
| 78 | KURA ONCOLOGY IN | KURA | 166,526 | $3.3M | 0.26% |
| 79 | MADRIGAL PHARMACEUTICALS INC | MDGL | 15,300 | $3.2M | 0.26% |
| 80 | ARVINAS INC | ARVN | 130,500 | $3.2M | 0.26% |
| 81 | KRYSTAL BIOTECH INC | KRYS | 17,000 | $3.1M | 0.25% |
| 82 | IGM BIOSCIENCES INC | 449585108 | 185,459 | $3.1M | 0.25% |
| 83 | BRUKER CORP | BRKRP | 44,315 | $3.1M | 0.25% |
| 84 | ARCELLX INC | ACLX | 32,000 | $2.7M | 0.22% |
| 85 | MEDPACE HLDGS INC | MEDP | 7,500 | $2.5M | 0.20% |
| 86 | UNIVERSAL HLTH SVCS INC | 913903100 | 8,000 | $1.8M | 0.15% |
| 87 | IMMUNOCORE HLDGS PLC | IMCR | 58,278 | $1.8M | 0.15% |
| 88 | PRIVIA HEALTH GROUP INC | PRVA | 95,189 | $1.7M | 0.14% |
| 89 | BIO-TECHNE CORP | TECH | 20,000 | $1.6M | 0.13% |
| 90 | REPLIGEN CORP | RGEN | 10,000 | $1.5M | 0.12% |
| 91 | XENON PHARMACEUTICALS INC | XENE | 35,000 | $1.4M | 0.11% |
| 92 | PLIANT THERAPEUTICS INC | PLRX | 120,250 | $1.3M | 0.11% |
| 93 | AVANTOR INC | AVTR | 44,000 | $1.1M | 0.09% |
| 94 | AMGEN INC | AMGN | 3,000 | $966,630 | 0.08% |
| 95 | INMUNE BIO INC | INMB | 178,284 | $960,951 | 0.08% |